Current Headlines

  1. Backed By Baxter, Harvard's Wyss Institute Launches Sepsis Therapy Startup, Opsonix

    The Wyss Institute for Biologically Inspired Engineering at Harvard University has unveiled the launch of its start-up company Opsonix Inc. The announcement follows a worldwide exclusive licensing agreement between Harvard's Office of Technology Development (OTD) and Opsonix Inc. enabling the company to ready the Wyss-designed sepsis therapy for clinical use.

  2. GE, StartUp Health Academy To Admit More Digital Health Entrepreneurs

    GE Ventures and StartUp Health are expanding their startup program, which aids early-stage healthcare and medtech companies needing initial funding and mentorship towards maturity. The entrepreneurship program will admit a new batch of startups working in the areas of virtual health platforms and next-generation payment solutions.

  3. DARPA Begins Funding “Electroceutical” Research

    The Defense Advanced Research Projects Agency (DARPA) has launched the first seven research projects of its Electrical Prescriptions (ElectRx) program, which seeks to reframe the approach to modern medicine and chronic illness by studying and treating the body as a system of electrical circuits.

  4. CDC-Funded Study Proves Germ-Killing Robot Can Help Hospitals Reduce HAIs

    Tru-D SmartUVC LLC will feature its UVC automated disinfection robot, the sole device used in the landmark Benefits of Enhanced Terminal Room Disinfection study, at IDWeek 2015 in San Diego through Oct. 11. The study was funded by the Centers for Disease Control and performed by researchers with the Duke Infection Control Outreach Network.

  5. Report: Medtech Market Consolidation Tempered By Flat Growth, Decreased Early-Stage Financing

    Despite record M&A dealing and IPO activity, as well as a boost in R&D funding in the past year, the global medtech industry is experiencing tepid organic growth and a slowdown in early-stage financing that could threaten innovation, a new report indicates. In 2014, public medtech companies worldwide grew just two percent, marking the second consecutive year the industry has posted single-digit top-line growth.

  6. Fast-Track Bill Will Include Medical Device Tax Repeal

    Committees in the U.S. House of Representatives are considering proposals to repeal several key Affordable Care Act (ACA) provisions, including the medical device tax, as part of a congressional budget tool called a reconciliation bill. Leaders in the med tech industry see the tax as an unnecessary drag on research spending and technology innovation, which a recent report suggests could reduce overall healthcare spending.

  7. Mayo Clinic Receives $6.8M Grant To Develop Devices That Predict, Stop Seizures

    Researchers at Mayo Clinic were awarded a $6.8 million federal grant from the National Institutes of Health to develop intelligent devices to track and treat abnormal brain activity in people with epilepsy. The grant, part of a presidential initiative aimed at revolutionizing the understanding of the human brain, is called Brain Research Through Advancing Innovative Neurotechnologies or the BRAIN Initiative.

  8. Report: By 2020, Global Medtech Market Worth $477.5 Billion, Medtronic Top Device Maker

    A recent report from market intelligence firm Evaluate Ltd. projects the global medtech market to grow 4.1 percent annually between 2014 and 2020, reaching $477.5 billion by the end of the decade. In addition, Medtronic is expected to overtake Johnson & Johnson as the largest medical device maker in the world by 2020.

  9. Boston Scientific Earns FDA’s First Approval For Bioabsorbable Polymer-Coated Stent

    The FDA has signed off on Boston Scientific’s SYNERGY Bioabsorbable Polymer Drug-Eluting Stent System (BP-DES), which was designed to reduce risk of long-term polymer exposure and improve arterial healing in patients with coronary artery disease. SYNERGY is designed so that the drug and polymers dissolve at the same rate, over three months of use.

  10. UV Light-Enabled Catheter Fixes Holes In The Heart Without Invasive Surgery

    Researchers from Boston Children's Hospital, the Wyss Institute for Biologically Inspired Engineering at Harvard University, Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) and the Karp Lab at Brigham and Women's Hospital have jointly designed a specialized catheter for fixing holes in the heart using a biodegradable adhesive and patch. The catheter has been used successfully in animal studies to facilitate hole closure without the need for open heart surgery.